BofA analyst Tazeen Ahmad raised the firm’s price target on Incyte (INCY) to $109 from $104 and keeps a Buy rating on the shares after FY25 revenue guidance was raised following a “strong” Q3 beat. The firm remains “encouraged by the strong performance of the commercial portfolio” and sees several upcoming catalysts for the pipeline, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INCY: